MedPath
TGA Approval

DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial (322685)

322685

DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial

Janssen-Cilag Pty Ltd

September 8, 2020

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/d0cfa90eb8f7844757d798c8f67e807d.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/590bb55c154fea6236e523c12bc2eb70.pdf

Active Ingredients

daratumumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

DARZALEX SC daratumumab 1800 mg/15 mL solution for injection vial (322685) - TGA 批准文号 | MedPath